| Frank E Politzer, MD | |
|
2605 Keiser Blvd, Wyomissing, PA 19610 | |
| (610) 685-8500 | |
| (610) 378-5131 |
| Full Name | Frank E Politzer |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 44 Years |
| Location | 2605 Keiser Blvd, Wyomissing, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205826658 | NPI | - | NPPES |
| 0011348870004 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD-041557-E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Medical Center | Reading, PA | Hospital |
| Reading Hospital | West reading, PA | Hospital |
| Schuylkill Medical Center - South Jackson Street | Pottsville, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Penn State Health Community Medical Group Llc | 8729351077 | 646 |
News Archive
Late stage pancreatic cancer benefits from photodynamic therapy (PDT) but the resources needed for the usual accompanying dosimetry present barriers, Dartmouth researchers Jonathan T. Elliott, PhD and Brian C. Pogue, PhD have mitigated by using common clinical technologies.
Researchers at the University of Hertfordshire are leading two of the twenty-one new Government-funded projects into dementia research - to boost dementia diagnosis rates and trial ground-breaking treatments, as well as helping people with dementia live well with the condition today.
Warner Chilcott plc today announced a recapitalization pursuant to which it intends to incur, subject to market and other conditions, $2.25 billion of new debt to fund a special dividend to Warner Chilcott's ordinary shareholders of $8.50 per share, or approximately $2.15 billion in the aggregate. The new debt is expected to be comprised of a combination of senior secured term loans and additional unsecured debt.
University of South Florida Department of Neurosurgery and Brain Repair faculty members have received a $2.6 million grant from the National Institutes of Health to investigate the potential for cells derived from human bone marrow to benefit post-stroke patients by repairing the blood-brain barrier.
Biota Holdings Limited and MedImmune Inc. today announced the start of a Phase Ia clinical trial for their respiratory syncytial virus (RSV) antiviral drug, BTA9881, with the goal of providing a treatment for RSV-infected infants and adults.
› Verified 8 days ago
| Entity Name | The Milton S Hershey Medical Center Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710951744 PECOS PAC ID: 3870405483 Enrollment ID: O20040225000741 |
News Archive
Late stage pancreatic cancer benefits from photodynamic therapy (PDT) but the resources needed for the usual accompanying dosimetry present barriers, Dartmouth researchers Jonathan T. Elliott, PhD and Brian C. Pogue, PhD have mitigated by using common clinical technologies.
Researchers at the University of Hertfordshire are leading two of the twenty-one new Government-funded projects into dementia research - to boost dementia diagnosis rates and trial ground-breaking treatments, as well as helping people with dementia live well with the condition today.
Warner Chilcott plc today announced a recapitalization pursuant to which it intends to incur, subject to market and other conditions, $2.25 billion of new debt to fund a special dividend to Warner Chilcott's ordinary shareholders of $8.50 per share, or approximately $2.15 billion in the aggregate. The new debt is expected to be comprised of a combination of senior secured term loans and additional unsecured debt.
University of South Florida Department of Neurosurgery and Brain Repair faculty members have received a $2.6 million grant from the National Institutes of Health to investigate the potential for cells derived from human bone marrow to benefit post-stroke patients by repairing the blood-brain barrier.
Biota Holdings Limited and MedImmune Inc. today announced the start of a Phase Ia clinical trial for their respiratory syncytial virus (RSV) antiviral drug, BTA9881, with the goal of providing a treatment for RSV-infected infants and adults.
› Verified 8 days ago
| Entity Name | Penn State Health Community Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861988644 PECOS PAC ID: 8729351077 Enrollment ID: O20170907002279 |
News Archive
Late stage pancreatic cancer benefits from photodynamic therapy (PDT) but the resources needed for the usual accompanying dosimetry present barriers, Dartmouth researchers Jonathan T. Elliott, PhD and Brian C. Pogue, PhD have mitigated by using common clinical technologies.
Researchers at the University of Hertfordshire are leading two of the twenty-one new Government-funded projects into dementia research - to boost dementia diagnosis rates and trial ground-breaking treatments, as well as helping people with dementia live well with the condition today.
Warner Chilcott plc today announced a recapitalization pursuant to which it intends to incur, subject to market and other conditions, $2.25 billion of new debt to fund a special dividend to Warner Chilcott's ordinary shareholders of $8.50 per share, or approximately $2.15 billion in the aggregate. The new debt is expected to be comprised of a combination of senior secured term loans and additional unsecured debt.
University of South Florida Department of Neurosurgery and Brain Repair faculty members have received a $2.6 million grant from the National Institutes of Health to investigate the potential for cells derived from human bone marrow to benefit post-stroke patients by repairing the blood-brain barrier.
Biota Holdings Limited and MedImmune Inc. today announced the start of a Phase Ia clinical trial for their respiratory syncytial virus (RSV) antiviral drug, BTA9881, with the goal of providing a treatment for RSV-infected infants and adults.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Frank E Politzer, MD 2605 Keiser Blvd, Wyomissing, PA 19610 Ph: (610) 685-8500 | Frank E Politzer, MD 2605 Keiser Blvd, Wyomissing, PA 19610 Ph: (610) 685-8500 |
News Archive
Late stage pancreatic cancer benefits from photodynamic therapy (PDT) but the resources needed for the usual accompanying dosimetry present barriers, Dartmouth researchers Jonathan T. Elliott, PhD and Brian C. Pogue, PhD have mitigated by using common clinical technologies.
Researchers at the University of Hertfordshire are leading two of the twenty-one new Government-funded projects into dementia research - to boost dementia diagnosis rates and trial ground-breaking treatments, as well as helping people with dementia live well with the condition today.
Warner Chilcott plc today announced a recapitalization pursuant to which it intends to incur, subject to market and other conditions, $2.25 billion of new debt to fund a special dividend to Warner Chilcott's ordinary shareholders of $8.50 per share, or approximately $2.15 billion in the aggregate. The new debt is expected to be comprised of a combination of senior secured term loans and additional unsecured debt.
University of South Florida Department of Neurosurgery and Brain Repair faculty members have received a $2.6 million grant from the National Institutes of Health to investigate the potential for cells derived from human bone marrow to benefit post-stroke patients by repairing the blood-brain barrier.
Biota Holdings Limited and MedImmune Inc. today announced the start of a Phase Ia clinical trial for their respiratory syncytial virus (RSV) antiviral drug, BTA9881, with the goal of providing a treatment for RSV-infected infants and adults.
› Verified 8 days ago
Nirav R. Shah, MD, MPH Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1011 Reed Ave, Suite 300, Wyomissing, PA 19610 Phone: 610-374-4401 Fax: 610-374-7140 | |
Dr. David F Steffy, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 950b N Wyomissing Blvd, 3rd Floor, Wyomissing, PA 19610 Phone: 610-898-1820 Fax: 610-372-0164 | |
Dr. Michael Bernard Russo, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2605 Keiser Blvd, Wyomissing, PA 19610 Phone: 610-685-8500 Fax: 610-685-4833 | |
Dr. Pallak Agarwal, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2608 Keiser Blvd, Wyomissing, PA 19610 Phone: 610-685-5864 Fax: 610-929-1528 | |
Dr. Kristie Marie Pepper, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2760 Century Blvd, Wyomissing, PA 19610 Phone: 610-375-4251 Fax: 610-685-2870 | |
Louis La Luna, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1011 Reed Ave, Suite 300, Wyomissing, PA 19610 Phone: 610-374-4401 Fax: 610-374-7140 | |
Tara Lynn Dimino, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2605 Keiser Blvd, Wyomissing, PA 19610 Phone: 610-685-8500 Fax: 610-685-4833 |